Publications

Found 2 results
Filters: Author is X.T. Cai  [Clear All Filters]
2016
N. Wang, Zhang, J. B., Zhao, J., Cai, X. T., Zhu, Y. S., Li, S. B., Wang, N., Zhang, J. B., Zhao, J., Cai, X. T., Zhu, Y. S., and Li, S. B., Association between dopamine D2 receptor gene polymorphisms and the risk of heroin dependence, vol. 15, no. 4, p. -, 2016.
Conflicts of interestThe authors declare no conflict of interest.ACKNOWLEDGMENTSResearch partially supported by the National Science Foundation of China (#NSFC31100900). REFERENCESAl-Eitan LN, Jaradat SA, Hulse GK, Tay GK, et al (2012). Custom genotyping for substance addiction susceptibility genes in Jordanians of Arab descent. BMC Res. Notes 5: 497. http://dx.doi.org/10.1186/1756-0500-5-497 Chen D, Liu F, Shang Q, Song X, et al (2011). Association between polymorphisms of DRD2 and DRD4 and opioid dependence: evidence from the current studies. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 156B: 661-670. http://dx.doi.org/10.1002/ajmg.b.31208 Clarke TK, Weiss AR, Ferarro TN, Kampman KM, et al (2014). The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction. Ann. Hum. Genet. 78: 33-39. http://dx.doi.org/10.1111/ahg.12046 Doehring A, Hentig Nv, Graff J, Salamat S, et al (2009). Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution. Pharmacogenet. Genomics 19: 407-414. http://dx.doi.org/10.1097/FPC.0b013e328320a3fd Duan J, Wainwright MS, Comeron JM, Saitou N, et al (2003). Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum. Mol. Genet. 12: 205-216. http://dx.doi.org/10.1093/hmg/ddg055 Gorwood P, Le Strat Y, Ramoz N, Dubertret C, et al (2012). Genetics of dopamine receptors and drug addiction. Hum. Genet. 131: 803-822. http://dx.doi.org/10.1007/s00439-012-1145-7 Gupta M, Chauhan C, Bhatnagar P, Gupta S, et al (2009). Genetic susceptibility to schizophrenia: role of dopaminergic pathway gene polymorphisms. Pharmacogenomics 10: 277-291. http://dx.doi.org/10.2217/14622416.10.2.277 Hou QF, Li SB, et al (2009). Potential association of DRD2 and DAT1 genetic variation with heroin dependence. Neurosci. Lett. 464: 127-130. http://dx.doi.org/10.1016/j.neulet.2009.08.004 Huang CL, Ou WC, Chen PL, Liu CN, et al (2015). Effects of interaction between dopamine D2 receptor and monoamine oxidase A genes on smoking status in young men. Biol. Res. Nurs. 17: 422-428. http://dx.doi.org/10.1177/1099800415589366 Hwang R, Shinkai T, De Luca V, Müller DJ, et al (2005). Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populations. Psychopharmacology (Berl.) 181: 179-187. http://dx.doi.org/10.1007/s00213-005-2223-5 Iida K, Akashi H, et al (2000). A test of translational selection at ‘silent’ sites in the human genome: base composition comparisons in alternatively spliced genes. Gene 261: 93-105. http://dx.doi.org/10.1016/S0378-1119(00)00482-0 Jönsson EG, Nöthen MM, Grünhage F, Farde L, et al (1999). Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol. Psychiatry 4: 290-296. http://dx.doi.org/10.1038/sj.mp.4000532 Kukreti R, Tripathi S, Bhatnagar P, Gupta S, et al (2006). Association of DRD2 gene variant with schizophrenia. Neurosci. Lett. 392: 68-71. http://dx.doi.org/10.1016/j.neulet.2005.08.059 Liu JH, Zhong HJ, Dang J, Peng L, et al (2015). Single-nucleotide polymorphisms in dopamine receptor D1 are associated with heroin dependence but not impulsive behavior. Genet. Mol. Res. 14: 4041-4050. http://dx.doi.org/10.4238/2015.April.27.19 Maldonado R, Saiardi A, Valverde O, Samad TA, et al (1997). Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 388: 586-589. http://dx.doi.org/10.1038/41567 Meyers JL, Nyman E, Loukola A, Rose RJ, et al (2013). The association between DRD2/ANKK1 and genetically informed measures of alcohol use and problems. Addict. Biol. 18: 523-536. http://dx.doi.org/10.1111/j.1369-1600.2012.00490.x Moyer RA, Wang D, Papp AC, Smith RM, et al (2011). Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse. Neuropsychopharmacology 36: 753-762. http://dx.doi.org/10.1038/npp.2010.208 Parsian A, Cloninger CR, Zhang ZH, et al (2000). Functional variant in the DRD2 receptor promoter region and subtypes of alcoholism. Am. J. Med. Genet. 96: 407-411. http://dx.doi.org/10.1002/1096-8628(20000612)96:3<407::AID-AJMG32>3.0.CO;2-1 Prasad P, Ambekar A, Vaswani M, et al (2010). Dopamine D2 receptor polymorphisms and susceptibility to alcohol dependence in Indian males: a preliminary study. BMC Med. Genet. 11: 24. http://dx.doi.org/10.1186/1471-2350-11-24 Rangel-Barajas C, Coronel I, Florán B, et al (2015). Dopamine receptors and neurodegeneration. Aging Dis. 6: 349-368. http://dx.doi.org/10.14336/AD.2015.0330 Ritchie T, Noble EP, et al (2003). Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics. Neurochem. Res. 28: 73-82. http://dx.doi.org/10.1023/A:1021648128758 Rowlett JK, Platt DM, Yao WD, Spealman RD, et al (2007). Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys. J. Pharmacol. Exp. Ther. 321: 1135-1143. http://dx.doi.org/10.1124/jpet.107.120766 Teh LK, Izuddin AF, M H FH, Zakaria ZA, et al (2012). Tridimensional personalities and polymorphism of dopamine D2 receptor among heroin addicts. Biol. Res. Nurs. 14: 188-196. http://dx.doi.org/10.1177/1099800411405030 Uhl GR, Drgon T, Johnson C, Fatusin OO, et al (2008). “Higher order” addiction molecular genetics: convergent data from genome-wide association in humans and mice. Biochem. Pharmacol. 75: 98-111. http://dx.doi.org/10.1016/j.bcp.2007.06.042 van den Bree MB, Johnson EO, Neale MC, Pickens RW, et al (1998). Genetic and environmental influences on drug use and abuse/dependence in male and female twins. Drug Alcohol Depend. 52: 231-241. http://dx.doi.org/10.1016/S0376-8716(98)00101-X Vereczkei A, Demetrovics Z, Szekely A, Sarkozy P, et al (2013). Multivariate analysis of dopaminergic gene variants as risk factors of heroin dependence. PLoS One 8: e66592. http://dx.doi.org/10.1371/journal.pone.0066592 Wang GJ, Volkow ND, Fowler JS, Logan J, et al (1997). Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal. Neuropsychopharmacology 16: 174-182. http://dx.doi.org/10.1016/S0893-133X(96)00184-4 Xu K, Lichtermann D, Lipsky RH, Franke P, et al (2004). Association of specific haplotypes of D2 dopamine receptor gene with vulnerability to heroin dependence in 2 distinct populations. Arch. Gen. Psychiatry 61: 597-606. http://dx.doi.org/10.1001/archpsyc.61.6.597 Zhang JP, Lencz T, Malhotra AK, et al (2010). D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis. Am. J. Psychiatry 167: 763-772. http://dx.doi.org/10.1176/appi.ajp.2009.09040598 Zhang Y, Bertolino A, Fazio L, Blasi G, et al (2007). Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc. Natl. Acad. Sci. USA 104: 20552-20557. http://dx.doi.org/10.1073/pnas.0707106104  
N. Wang, Zhang, J. B., Zhao, J., Cai, X. T., Zhu, Y. S., Li, S. B., Wang, N., Zhang, J. B., Zhao, J., Cai, X. T., Zhu, Y. S., and Li, S. B., Association between dopamine D2 receptor gene polymorphisms and the risk of heroin dependence, vol. 15, no. 4, p. -, 2016.
Conflicts of interestThe authors declare no conflict of interest.ACKNOWLEDGMENTSResearch partially supported by the National Science Foundation of China (#NSFC31100900). REFERENCESAl-Eitan LN, Jaradat SA, Hulse GK, Tay GK, et al (2012). Custom genotyping for substance addiction susceptibility genes in Jordanians of Arab descent. BMC Res. Notes 5: 497. http://dx.doi.org/10.1186/1756-0500-5-497 Chen D, Liu F, Shang Q, Song X, et al (2011). Association between polymorphisms of DRD2 and DRD4 and opioid dependence: evidence from the current studies. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 156B: 661-670. http://dx.doi.org/10.1002/ajmg.b.31208 Clarke TK, Weiss AR, Ferarro TN, Kampman KM, et al (2014). The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction. Ann. Hum. Genet. 78: 33-39. http://dx.doi.org/10.1111/ahg.12046 Doehring A, Hentig Nv, Graff J, Salamat S, et al (2009). Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution. Pharmacogenet. Genomics 19: 407-414. http://dx.doi.org/10.1097/FPC.0b013e328320a3fd Duan J, Wainwright MS, Comeron JM, Saitou N, et al (2003). Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum. Mol. Genet. 12: 205-216. http://dx.doi.org/10.1093/hmg/ddg055 Gorwood P, Le Strat Y, Ramoz N, Dubertret C, et al (2012). Genetics of dopamine receptors and drug addiction. Hum. Genet. 131: 803-822. http://dx.doi.org/10.1007/s00439-012-1145-7 Gupta M, Chauhan C, Bhatnagar P, Gupta S, et al (2009). Genetic susceptibility to schizophrenia: role of dopaminergic pathway gene polymorphisms. Pharmacogenomics 10: 277-291. http://dx.doi.org/10.2217/14622416.10.2.277 Hou QF, Li SB, et al (2009). Potential association of DRD2 and DAT1 genetic variation with heroin dependence. Neurosci. Lett. 464: 127-130. http://dx.doi.org/10.1016/j.neulet.2009.08.004 Huang CL, Ou WC, Chen PL, Liu CN, et al (2015). Effects of interaction between dopamine D2 receptor and monoamine oxidase A genes on smoking status in young men. Biol. Res. Nurs. 17: 422-428. http://dx.doi.org/10.1177/1099800415589366 Hwang R, Shinkai T, De Luca V, Müller DJ, et al (2005). Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populations. Psychopharmacology (Berl.) 181: 179-187. http://dx.doi.org/10.1007/s00213-005-2223-5 Iida K, Akashi H, et al (2000). A test of translational selection at ‘silent’ sites in the human genome: base composition comparisons in alternatively spliced genes. Gene 261: 93-105. http://dx.doi.org/10.1016/S0378-1119(00)00482-0 Jönsson EG, Nöthen MM, Grünhage F, Farde L, et al (1999). Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol. Psychiatry 4: 290-296. http://dx.doi.org/10.1038/sj.mp.4000532 Kukreti R, Tripathi S, Bhatnagar P, Gupta S, et al (2006). Association of DRD2 gene variant with schizophrenia. Neurosci. Lett. 392: 68-71. http://dx.doi.org/10.1016/j.neulet.2005.08.059 Liu JH, Zhong HJ, Dang J, Peng L, et al (2015). Single-nucleotide polymorphisms in dopamine receptor D1 are associated with heroin dependence but not impulsive behavior. Genet. Mol. Res. 14: 4041-4050. http://dx.doi.org/10.4238/2015.April.27.19 Maldonado R, Saiardi A, Valverde O, Samad TA, et al (1997). Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 388: 586-589. http://dx.doi.org/10.1038/41567 Meyers JL, Nyman E, Loukola A, Rose RJ, et al (2013). The association between DRD2/ANKK1 and genetically informed measures of alcohol use and problems. Addict. Biol. 18: 523-536. http://dx.doi.org/10.1111/j.1369-1600.2012.00490.x Moyer RA, Wang D, Papp AC, Smith RM, et al (2011). Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse. Neuropsychopharmacology 36: 753-762. http://dx.doi.org/10.1038/npp.2010.208 Parsian A, Cloninger CR, Zhang ZH, et al (2000). Functional variant in the DRD2 receptor promoter region and subtypes of alcoholism. Am. J. Med. Genet. 96: 407-411. http://dx.doi.org/10.1002/1096-8628(20000612)96:3<407::AID-AJMG32>3.0.CO;2-1 Prasad P, Ambekar A, Vaswani M, et al (2010). Dopamine D2 receptor polymorphisms and susceptibility to alcohol dependence in Indian males: a preliminary study. BMC Med. Genet. 11: 24. http://dx.doi.org/10.1186/1471-2350-11-24 Rangel-Barajas C, Coronel I, Florán B, et al (2015). Dopamine receptors and neurodegeneration. Aging Dis. 6: 349-368. http://dx.doi.org/10.14336/AD.2015.0330 Ritchie T, Noble EP, et al (2003). Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics. Neurochem. Res. 28: 73-82. http://dx.doi.org/10.1023/A:1021648128758 Rowlett JK, Platt DM, Yao WD, Spealman RD, et al (2007). Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys. J. Pharmacol. Exp. Ther. 321: 1135-1143. http://dx.doi.org/10.1124/jpet.107.120766 Teh LK, Izuddin AF, M H FH, Zakaria ZA, et al (2012). Tridimensional personalities and polymorphism of dopamine D2 receptor among heroin addicts. Biol. Res. Nurs. 14: 188-196. http://dx.doi.org/10.1177/1099800411405030 Uhl GR, Drgon T, Johnson C, Fatusin OO, et al (2008). “Higher order” addiction molecular genetics: convergent data from genome-wide association in humans and mice. Biochem. Pharmacol. 75: 98-111. http://dx.doi.org/10.1016/j.bcp.2007.06.042 van den Bree MB, Johnson EO, Neale MC, Pickens RW, et al (1998). Genetic and environmental influences on drug use and abuse/dependence in male and female twins. Drug Alcohol Depend. 52: 231-241. http://dx.doi.org/10.1016/S0376-8716(98)00101-X Vereczkei A, Demetrovics Z, Szekely A, Sarkozy P, et al (2013). Multivariate analysis of dopaminergic gene variants as risk factors of heroin dependence. PLoS One 8: e66592. http://dx.doi.org/10.1371/journal.pone.0066592 Wang GJ, Volkow ND, Fowler JS, Logan J, et al (1997). Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal. Neuropsychopharmacology 16: 174-182. http://dx.doi.org/10.1016/S0893-133X(96)00184-4 Xu K, Lichtermann D, Lipsky RH, Franke P, et al (2004). Association of specific haplotypes of D2 dopamine receptor gene with vulnerability to heroin dependence in 2 distinct populations. Arch. Gen. Psychiatry 61: 597-606. http://dx.doi.org/10.1001/archpsyc.61.6.597 Zhang JP, Lencz T, Malhotra AK, et al (2010). D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis. Am. J. Psychiatry 167: 763-772. http://dx.doi.org/10.1176/appi.ajp.2009.09040598 Zhang Y, Bertolino A, Fazio L, Blasi G, et al (2007). Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc. Natl. Acad. Sci. USA 104: 20552-20557. http://dx.doi.org/10.1073/pnas.0707106104